RHY 0.00% 4.7¢ rhythm biosciences limited

I just can't understand how RHY can sell COLOSTAT in the near to...

  1. 1,251 Posts.
    lightbulb Created with Sketch. 101

    I just can't understand how RHY can sell COLOSTAT in the near to medium term

    Not published in medial journals that I am aware of
    Not recognised/mentioned by any scientists outside of RHY
    Not presenting at Australian conferences to showcase COLOSTAT
    Not presenting at World conferences to showcase COLOSTAT
    No disclosure of sensitivity and specificity for all stages of cancer
    No disclosure of sensitivity and specificity for advanced adenomas


    Just because RHY has found 2 manufacturing (micro caps) to make the COLOSTAT test kit doesn't mean it will produce them. A lot of water needs to go under the bridge.

    FirstSight is not quite ready for commercialisation but far more advanced than RHY with everything they do. They were going down the path of CLIA but due to above average results they are now pursuing the FDA route. This will 100% ensure medicare/medicaid reimburesment.

    It will sell for under $200.

    Before you say that blood-based testing requires basically NO capital investment, any capital investment and training for a superior product will have a very quick pay off.

    Whether these CRC blood testing companies around the world start selling in Australia is anyone's guess.

    https://www.medindia.net/health-press-release/cellmax-life-announces-positive-results-from-prospective-multisite-study-of-novel-blood-test-to-detect-colorectal-cancer-and-pre--615923-1.htm

    https://www.prweb.com/releases/2023/1/prweb19120238.htm

    https://cellmaxlife.com/


 
watchlist Created with Sketch. Add RHY (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.